PROXEON BIOSYSTEMS ApS: Financial statements 2014
CVR: 26848024
PROXEON BIOSYSTEMS ApS (CVR 26848024) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 58,387,340 and a net result of DKK 45,488,263 compared with DKK 29,689,306 the year before. That is an increase of 20.6% compared with the year before. Equity amounted to DKK 138,119,178. The solvency ratio was 86.6%.
- Gross Profit
- 58,387,340 kr.
- Profit/Loss
- 45,488,263 kr.
- Equity
- 138,119,178 kr.
- Total Assets
- 159,445,271 kr.
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | 58.4 mio. | 45.5 mio. | 138.1 mio. | 0 |
| 2013 | - | 48.4 mio. | 29.7 mio. | 92.6 mio. | 28 |
| 2012 | - | 37.9 mio. | 22 mio. | 63 mio. | 36 |
Keep an eye on PROXEON BIOSYSTEMS ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2014
PROXEON BIOSYSTEMS ApS has published its annual report for 2013. Gross profit came to DKK 48,414,610, and the net result was DKK 29,689,306.
As of January 1, 2014, Grant Hellier Lawrence is registered as director of PROXEON BIOSYSTEMS ApS.
As of January 1, 2014, Ole Vorm has stepped down as director of PROXEON BIOSYSTEMS ApS.
About PROXEON BIOSYSTEMS ApS
PROXEON BIOSYSTEMS ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2002. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Simon Lie. The company is owned by NUNC A/S. The company has 0 employees. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 2,950,000 compared with DKK 3,703,000 the year before. Equity amounted to DKK 386,590,000.
